2021-10-26 来源 : VIP说
化疗和早期姑息治疗
▼ 表1. 接受肿瘤治疗和姑息治疗的获益:关键研究汇总
早期姑息治疗(EPC)的作用机制
非小细胞肺癌(NSCLC)的免疫治疗
免疫疗法 vs 姑息治疗
免疫疗法和阿片类药物
结论
参考文献
1. Pieniążek M, PawlakP, Radecka B. Early palliative care of non-small cell lung cancer in thecontext of immunotherapy. Oncol Lett. 2020; 20(6): 396.
2. Rinaldi S,Marcantognini G, Fiordoliva I, et. al. The negative prognostic role of opioidsin patients with NSCLC treated with immunotherapy. Presented at MASCC/ISOOAnnual Meeting on Supportive Care in Cancer, San Francisco, CA, 2019.
3. Arbour KC, MezquitaL, Long N, Rizvi H, Auclin E, Ni A, Martínez‑Bernal G, Ferrara R,Lai WV , Hendriks LEL, et al. Impact of baseline steroids on efficacy ofprogrammed cell death‑1 and programmed death‑ligand 1 blockade in patients with non–small cell lung cancer. J ClinOncol. 2018; 36(28): 2872‑2878.
4. De Giglio A,Mezquita L, Auclin E, et al. Impact of early introduction of steroid on immune‑checkpoint inhibitors (ICI) in patients with advanced non‑small cell lung cancer treated. Ann Oncol. 2019; 30 (s11): xi16.
5. Derosa L, HellmannMD, Spaziano M, et al. Negative association of antibiotics on clinical activityof immune checkpoint inhibitors in patients with advanced renal cell and non‑small cell lung cancer. Ann Oncol. 2018; 29(6): 1437‑1444.
版权声明:本网站所有注明来源“医微客”的文字、图片和音视频资料,版权均属于医微客所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源:”医微客”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,转载仅作观点分享,版权归原作者所有。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。 本站拥有对此声明的最终解释权。
发表评论
注册或登后即可发表评论
登录注册
全部评论(0)